Connect Biopharma(CNTB) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CNTB Connect Biopharma

Watchlist

0.5500
-0.1300-19.12%

Close Mar 31 16:00 ET

30.31MMarket Cap-1.41P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Connect Biopharma Reports Data From Global Phase 2 Trial Of Rademikibart In Patients With Moderate-To-Severe Uncontrolled Asthma
Benzinga16:09 ET
Express News | HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $8 Price Target
Benzinga12:37 ET
Connect Biopharma Hldgs Analyst Ratings
Benzinga12:34 ET · Ratings
Express News | Connect Biopharma Holdings Ltd - Phase 2 Trials for Rademikibart to Start in 2Q 2025, Data Expected in H2 2026 - SEC Filing
ReutersMar 31 09:24 ET
Connect Biopharma Reports FY24 (28c) Vs ($1.13) Last Year
TipRanksMar 31 09:11 ET
Express News | Connect Biopharma FY25 EPS $(0.28) Up From $(1.13) YoY; Revenue $26M
BenzingaMar 31 09:05 ET

Comments

Jaguar8

2 hours ago

NEWS

$Connect Biopharma (CNTB.US)$
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
Monday, 31st March at 4:05 pm
– Rademikibart demonstrated rapid onset of action with significant improvements in lung function observed at one week and maintained through 24 weeks –
– In patients with eosinophilic-driven asthma (≥300 eosinophils/µL) receiving rademikibart for 24 weeks, the mean difference fro...

Teddy123

9 hours ago

Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update

$Connect Biopharma (CNTB.US)$
Connect Biopharma Achieves Major Turnaround: $26M Revenue, Slashes Losses, Plans Key Clinical Trials

71129854

Jun 13, 2024 08:31

$Connect Biopharma (CNTB.US)$ Barry Quartz? Bad News!

Jaguar8

May 23, 2024 04:08

$Connect Biopharma (CNTB.US)$
NEWS
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma

Trytosaveabit

May 7, 2024 18:40

Watching for info outa this!

$Connect Biopharma (CNTB.US)$ Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma

Market Insights

Symbol Mini Chart % Chg

Collegium Pharmaceutical

COLL

+0.47%

Unlock the Full List